NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

Cover of Drugs and Lactation Database (LactMed)

Drugs and Lactation Database (LactMed) [Internet].

Show details

Paclitaxel

Last Revision: January 20, 2020.

Estimated reading time: 2 minutes

CASRN: 33069-62-4

image 134998291 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy.[1] Based on limited data, paclitaxel appears to be excreted into milk in relatively large amounts. It might be possible to breastfeed safely during intermittent therapy with an appropriate period of breastfeeding abstinence, but the duration abstinence is not clear. The manufacturer recommends that breastfeeding be discontinued during paclitaxel therapy and for 2 weeks after the last dose

Chemotherapy may adversely affect the normal microbiome and chemical makeup of breastmilk.[2] Women who receive chemotherapy during pregnancy are more likely to have difficulty nursing their infant.

Drug Levels

Maternal Levels. A woman with a history of treatment for thyroid cancer and recurrence during pregnancy was treated postpartum with paclitaxel and carboplatin. Her intravenous paclitaxel dose was 56.1 mg (30 mg per square meter) weekly for 6 weeks. Whole milk samples were obtained at 4, 28, 172, and 316 hours after the sixth dose. The highest milk paclitaxel level was 1.17 mg/L in the 28-hour sample and paclitaxel was undetectable (<80 mcg/L) in the 316 hour sample. Metabolites were not measured. The authors calculated an average milk paclitaxel level over the 316 hour collection period of 0.78 mg/L, resulting in an estimated total weight-adjusted infant daily dose of 16.7% of the maternal weekly dose.[3] Note that the above estimate of the infant daily dose is expressed as percentage of the maternal weekly dose, and that authors used a level of zero as the trough milk level, rather than a milk level taken before the sixth dose (which would equal approximately the 172-hour level of 0.97 mg/L), resulting in an underestimate of the AUC and infant dose.

A 17-week pregnant woman with breast cancer received a regimen of fluorouracil, epirubicin and cyclophosphamide, followed by 9 weekly doses of paclitaxel 80 mg/sq. m. Her infant was delivered after the 6th dose of paclitaxel. She pumped milk and discarded it until after the 9th dose of paclitaxel when maternal blood and milk samples were colleted. Paclitaxel concentration in milk was 111.4 mcg/L at 11 hours after the dose. Milk concentration decrease to 6.8 mcg/L at 27 hours after the dose. Milk paclitaxel levels were undetectable (<2.5 mcg/L) at 71.25 hours after the dose, and thereafter until 360 hours after the dose.[4]

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

A telephone follow-up study was conducted on 74 women who received cancer chemotherapy at one center during the second or third trimester of pregnancy to determine if they were successful at breastfeeding postpartum. Only 34% of the women were able to exclusively breastfeed their infants, and 66% of the women reported experiencing breastfeeding difficulties. This was in comparison to a 91% breastfeeding success rate in 22 other mothers diagnosed during pregnancy, but not treated with chemotherapy. Other statistically significant correlations included: 1. mothers with breastfeeding difficulties had an average of 5.5 cycles of chemotherapy compared with 3.8 cycles among mothers who had no difficulties; and 2. mothers with breastfeeding difficulties received their first cycle of chemotherapy on average 3.4 weeks earlier in pregnancy. Of the 9 women who received a taxane-containing regimen, 7 had breastfeeding difficulties.[5]

References

1.
Pistilli B, Bellettini G, Giovannetti E, et al. Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: How should we counsel cancer patients about breastfeeding? Cancer Treat Rev. 2013;39:207–11. [PubMed: 23199900]
2.
Urbaniak C, McMillan A, Angelini M, et al. Effect of chemotherapy on the microbiota and metabolome of human milk, a case report. Microbiome. 2014;2:24. [PMC free article: PMC4109383] [PubMed: 25061513]
3.
Griffin S, Milla M, Baker T, et al. Transfer of carboplatin and paclitaxel into breast milk. J Hum Lact. 2012;28:457–9. [PubMed: 23087196]
4.
Jackson C, Morris T, Hung N, et al. Breast milk paclitaxel excretion following intravenous chemotherapy-a case report. Br J Cancer. 2019;121:421–4. [PMC free article: PMC6738114] [PubMed: 31363168]
5.
Stopenski S, Aslam A, Zhang X, et al. After chemotherapy treatment for maternal cancer during pregnancy, is breastfeeding possible? Breastfeed Med. 2017;12:91–7. [PubMed: 28170295]

Substance Identification

Substance Name

Paclitaxel

CAS Registry Number

33069-62-4

Drug Class

Breast Feeding

Lactation

Antineoplastic Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site .

Views

Related information

Similar articles in PubMed

  • Review Docetaxel[Drugs and Lactation Database (...]
    Review Docetaxel
    . Drugs and Lactation Database (LactMed). 2006
  • Review Azacitidine[Drugs and Lactation Database (...]
    Review Azacitidine
    . Drugs and Lactation Database (LactMed). 2006
  • Review Vinblastine[Drugs and Lactation Database (...]
    Review Vinblastine
    . Drugs and Lactation Database (LactMed). 2006
  • Review Vinorelbine[Drugs and Lactation Database (...]
    Review Vinorelbine
    . Drugs and Lactation Database (LactMed). 2006
  • Review Mitoxantrone[Drugs and Lactation Database (...]
    Review Mitoxantrone
    . Drugs and Lactation Database (LactMed). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...